Navigation Links
BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
Date:11/6/2013

JERUSALEM, Nov. 6, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the quarter ended September 30, 2013 on Wednesday, November 13, 2013, before the U.S. markets open.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769)  

The Company will host a conference call on Wednesday, November 13 at 10:00 a.m. EST, featuring remarks by Kinneret Savitsky, Ph.D., Chief Executive Officer of BioLineRx, and Philip Serlin, Chief Financial and Operating Officer of BioLineRx.

The conference call will be available via webcast and can be accessed through the Investor Relations section of BioLineRx's website, www.biolinerx.com, and through www.kcsa.com. A presentation will be provided on BioLineRx's website, to accompany management's remarks during the conference call. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. To dial into the conference call, please dial 1-888-281-1167 from the U.S. or +972-3-918-0685 internationally.

A replay of the conference call will be available approximately two hours after completion of the live conference call at www.biolinerx.com or www.kcsa.com. A dial-in replay of the call will also be available until November 16, 2013. To access the replay, please dial 1-888-254-7270 from the U.S. or +972-3-925-5927 internationally.

About BioLineRx
BioLineRx is a publicly-traded biopharmaceutical development company dedicated to buildi
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
2. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
3. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
4. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
5. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
6. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
7. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
8. BioLineRx to Present at 15th International Celiac Disease Symposium
9. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
10. BioLineRx Appoints B. J. Bormann to Board of Directors
11. BioLineRx Reports Second Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  Over the next five ... continue to grow, with ArcView predicting that 14 more states ... medical marijuana. The U.S. market for legal cannabis grew 74 ... in 2013. Analysts project the market could grow more than ... more states soften their stance on marijuana. Cannabiz ...
(Date:4/17/2015)... 17, 2015   IBA Molecular, a global ... today that it has signed a definitive agreement to ... (IBAM NA), to Illinois Health and Science (IHS). Under IHS ... independent company headquartered in Dulles, Virginia ... of new product and footprint synergies. IBA Molecular is ...
(Date:4/17/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of cancer and diseases of the central ... three of its most advanced oncology programs at the ... Annual Meeting being held from April 18-22, 2015 ... The presentation on the BNC105 program describes ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5
... AMGN ) reported revenue unchanged for the third ... the third quarter of 2009. Adjusted net income ... of 2010 compared to $1,518 million for the third quarter ... by unusually low research and development (R&D) costs and favorable ...
... The National Community Pharmacists Association (NCPA) is partnering with ... of independent community pharmacies, an agreement announced during NCPA,s ... be able to more easily apply for the large ... traded chain pharmacies (CVS Caremark, Walgreens, etc.), which have ...
Cached Medicine Technology:Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 2Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 3Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 4Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 5Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 6Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 7Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 8Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 9Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 10Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 11Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 12Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 13Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 14Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 15NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases 2NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases 3
(Date:4/17/2015)... Canadian, Oklahoma (PRWEB) April 17, 2015 ... and Drug Dependence (NCADD) notes that drinking and driving ... attention. At the same time, the link between ... such as domestic abuse and violence and sexual assault, ... , According to the NCADD, 5.3 million adults in ...
(Date:4/17/2015)... “We have seen healing, a lot of healing, and a ... Shawn Kafader of Friendship Village. “People have found purpose. ... contribute have created beautiful pieces of art.” For the past ... that was launched to benefit residents of the retirement community. ... Art Institute in Chicago, worked as an intern at Friendship ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director ... April 15th, the European Parliament joined its voice with ... Armenian Genocide, “paying tribute, on the eve of the ... Armenian victims who perished in the Ottoman Empire.” ... this timely and needed recognition of a tragic episode ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 As ... above in his new offering of platelet-rich plasma ... Sports Medicine (MOSM) is known for its world-class ... Meier brings extensive surgical experience lacking in many other ... stem cell treatments are utilized for pain management and ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3
... ... Low Vision Conditions , ... Beach, CA (PRWEB) June 6, 2009 -- Enhanced Vision , America,s leading manufacturer of ... VISION 5K Run & Walk in Boston, MA this Saturday, June 7th. The unique event ...
... Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives ... Testing Day , , LOS ANGELES, June ... HIV prevention and testing efforts in some of the hardest ... (AHF), the nation,s largest non-profit AIDS organization, which currently ...
... US Oncology, Inc . (the "Company") ... sell an aggregate $775 million principal amount of 9 1/8% ... senior secured obligations of the Company. All of the ... and other existing capital market debt and specified future subsidiaries ...
... in finding ways to slow tumor growth , ... PHD2 that regulates blood vessel growth is often found ... levels of the protein in tumor samples and healthy ... researchers at Stanford University School of Medicine in California ...
... Anatomy, and ,Samantha Who?, to be Honored at Donate Life ... ANGELES, June 5 On June 13, Donate Life Hollywood ... and "Samantha Who?" with its first annual Inspire Award. This ... will be presented at the culmination of the daylong Donate ...
... say , FRIDAY, June 5 (HealthDay News) -- Couch potatoes ... games that require users to get up and move around, ... New research suggests that several exercise-based Nintendo Wii video games ... light jogging. , And seniors in Florida managed to raise ...
Cached Medicine News:Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 2Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 3Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 2Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 3Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 4Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 5Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 6Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 7Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 8Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 9Health News:Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST) 10Health News:New Debt Securities of US Oncology, Inc. 2Health News:New Debt Securities of US Oncology, Inc. 3Health News:ABC-TV Gets It Right According to Organ Donation Community 2Health News:Interactive Video Games Offer Exercise Benefits 2Health News:Interactive Video Games Offer Exercise Benefits 3
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 20G x 1 3/4in (.90 x 45cm) Silicone rod, length 13 3/4in (40cm), Diameter.032in (.80mm)...
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. For .20mm diameter holes and larger....
...
Medicine Products: